Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with (177)Lu-DOTATATE

We report the impact of (177)Lu-DOTATATE treatment on abdominal pain, diarrhea, and flushing, symptoms that patients with advanced midgut neuroendocrine tumors often find burdensome. Methods: All patients enrolled in the international randomized phase 3 Neuroendocrine Tumors Therapy (NETTER-1) trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Strosberg, Jonathan R., Srirajaskanthan, Rajaventhan, El-Haddad, Ghassan, Wolin, Edward M., Chasen, Beth A., Kulke, Matthew H., Bushnell, David L., Caplin, Martyn E., Baum, Richard P., Hendifar, Andrew E., Öberg, Kjell, Ruszniewski, Philippe, Santoro, Paola, Broberg, Per, Leeuwenkamp, Oscar R., Krenning, Eric P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2021
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612179/
https://www.ncbi.nlm.nih.gov/pubmed/33771903
http://dx.doi.org/10.2967/jnumed.120.258897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612179/
https://www.ncbi.nlm.nih.gov/pubmed/33771903
http://dx.doi.org/10.2967/jnumed.120.258897

Ejemplares similares